Tianqi Du

4PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 20, 2026
Unveiling the New Trick for Epigenetic Drug: Radiation Enhancement of Prostate Cancer by the EZH2 Inhibitor Tazemetostat.

|Mar 15, 2025
STAT1 increases the sensitivity of lung adenocarcinoma to carbon ion irradiation via HO-1-mediated ferroptosis.

Yanliang Chen, Dandan Wang, Hongtao Luo

|Oct 26, 2024
TGM2-Mediated Autophagy Contributes to the Radio-Resistance of Non-Small Cell Lung Cancer Stem-like Cells.

Qian Wang, Qiuning Zhang, Xiaohu Wang

|Nov 11, 2022
EZH2 as a Prognostic Factor and Its Immune Implication with Molecular Characterization in Prostate Cancer: An Integrated Multi-Omics in Silico Analysis.

Tian-Qi Du, Ruifeng Liu, Qiuning Zhang

Pageof 1

Frequent Collaborators

2 joint publications

Qian Wang

1 joint publications

Yi Xie

1 joint publications

Yanliang Chen

1 joint publications

Dandan Wang